Quick Order Cart

Cat. No. ARG38043

ANKRD54 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

ANKRD54 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T embryonic kidney epithelial cells, engineered for targeted disruption of the ANKRD54 gene. This model enables investigation of selective autophagy, where ANKRD54 functions as an adaptor that tethers cargo to LC3/GABARAP family proteins on autophagosomal membranes. Knockout of ANKRD54 impairs autophagic degradation of specific substrates, making these cells valuable for studying autophagy-related pathologies, cancer, and neurodegenerative diseases. Typical assays include western blotting of LC3-II turnover, immunofluorescence of LC3 puncta, and autophagy flux measurements, supporting drug screening and protein interaction studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ANKRD54

    Gene Identifier

    NCBI Gene ID 129138

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANKRD54 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HEK293T cell line, engineered for targeted disruption of the ANKRD54 gene. This polyclonal pool provides a versatile loss-of-function model for studying the role of ANKRD54 in autophagy and related cellular processes. Using CRISPR/Cas9-mediated gene disruption, these cells enable researchers to investigate functional consequences of ANKRD54 ablation without clonal isolation, preserving genetic diversity within the population.

HEK293T cells are a widely used embryonic kidney epithelial cell line derived from HEK293, stably expressing the SV40 large T-antigen. This antigen facilitates episomal replication of plasmids containing the SV40 origin, making HEK293T cells a preferred host for transient protein expression, viral packaging, and large-scale protein production. Their robust growth and ease of transfection render them ideal for high-throughput screening and mechanistic studies.

ANKRD54 encodes an ankyrin repeat domain-containing adaptor protein that functions in selective autophagy, a cellular degradation pathway for specific cargo. The protein is activated by upstream signals such as nutrient deprivation, mTOR inhibition, and TFEB transcription factor activity. ANKRD54 interacts directly with members of the LC3/GABARAP family (including LC3A, LC3B, GABARAP, GABARAPL1, and GABARAPL2), which are ATG8-family ubiquitin-like proteins conjugated to autophagosomal membranes. By tethering selective autophagic cargo to these membrane proteins, ANKRD54 facilitates cargo engulfment and lysosomal degradation. This places ANKRD54 downstream of core autophagy initiation components like ULK1, ATG13, BECN1, and ATG5, and upstream of degradation effectors such as p62 and lysosomal enzymes. Disruption of ANKRD54 impairs the autophagic flux of specific substrates, potentially disrupting cellular homeostasis and stress responses.

In HEK293T cells, knockout of ANKRD54 creates a valuable system to interrogate selective autophagy mechanisms. HEK293T cells have a well-characterized proteome and autophagy machinery, and the polyclonal knockout population avoids clonal artifacts while offering a genetically perturbed background for functional assays. The absence of ANKRD54 in these cells can lead to accumulation of autophagy substrates and altered LC3-II turnover, providing measurable endpoints. This model is particularly useful for dissecting the role of selective autophagy in endolysosomal trafficking, since ANKRD54 bridges cargo recognition and autophagosome formation. It also permits the study of cross-talk between autophagy and other cellular pathways under conditions of nutrient stress or pharmacological mTOR inhibition.

These polyclonal knockout cells are suitable for a broad range of applications, including mechanistic studies of selective autophagy, drug screening for autophagy modulators, and protein interaction analyses. Common assays include western blotting to monitor LC3-II levels and substrate accumulation, immunofluorescence to visualize LC3 puncta and lysosomal markers, co-immunoprecipitation to identify ANKRD54 interactors, autophagy flux assays using chloroquine treatment, RT-qPCR for autophagy gene expression profiling, flow cytometry for cell cycle and apoptosis analysis, and electron microscopy for autophagosome quantification. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)